BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 11504806)

  • 1. Regional patterns of compensation following genetic deletion of either 5-hydroxytryptamine(1A) or 5-hydroxytryptamine(1B) receptor in the mouse.
    Knobelman DA; Hen R; Blendy JA; Lucki I
    J Pharmacol Exp Ther; 2001 Sep; 298(3):1092-100. PubMed ID: 11504806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic regulation of extracellular serotonin by 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B) autoreceptors in different brain regions of the mouse.
    Knobelman DA; Hen R; Lucki I
    J Pharmacol Exp Ther; 2001 Sep; 298(3):1083-91. PubMed ID: 11504805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential involvement of 5-HT(1A) and 5-HT(1B/1D) receptors in human interferon-alpha-induced immobility in the mouse forced swimming test.
    Zhang H; Wang W; Jiang Z; Shang J; Zhang L
    Arzneimittelforschung; 2010; 60(3):109-15. PubMed ID: 20422941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of selective serotonin reuptake inhibitors on extracellular 5-HT levels in the hippocampus of 5-HT(1B) receptor knockout mice.
    De Groote L; Olivier B; Westenberg HG
    Eur J Pharmacol; 2002 Mar; 439(1-3):93-100. PubMed ID: 11937097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral and neurochemical effects of 5-(4-[4-(5-Cyano-3-indolyl)-butyl)-butyl]-1-piperazinyl)-benzofuran-2-carboxamide (EMD 68843): a combined selective inhibitor of serotonin reuptake and 5-hydroxytryptamine(1A) receptor partial agonist.
    Page ME; Cryan JF; Sullivan A; Dalvi A; Saucy B; Manning DR; Lucki I
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1220-7. PubMed ID: 12183683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of extracellular concentrations of 5-hydroxytryptamine (5-HT) in mouse striatum by 5-HT(1A) and 5-HT(1B) receptors.
    Knobelman DA; Kung HF; Lucki I
    J Pharmacol Exp Ther; 2000 Mar; 292(3):1111-7. PubMed ID: 10688630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular serotonin in the prefrontal cortex is limited through terminal 5-HT(1B) autoreceptors: a microdialysis study in knockout mice.
    de Groote L; Olivier B; Westenberg HG
    Psychopharmacology (Berl); 2002 Aug; 162(4):419-24. PubMed ID: 12172696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction between 5-HT(1A) and 5-HT(1B) receptors: effects of 8-OH-DPAT-induced hypothermia in 5-HT(1B) receptor knockout mice.
    Gardier AM; Gruwez B; Trillat AC; Jacquot C; Hen R; Bourin M
    Eur J Pharmacol; 2001 Jun; 421(3):171-5. PubMed ID: 11516433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo control of 5-hydroxytryptamine release by terminal autoreceptors in rat brain areas differentially innervated by the dorsal and median raphe nuclei.
    Hervás I; Bel N; Fernández AG; Palacios JM; Artigas F
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Sep; 358(3):315-22. PubMed ID: 9774218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic fluoxetine-induced desensitization of 5-HT1A and 5-HT1B autoreceptors: regional differences and effects of WAY-100635.
    Newman ME; Shalom G; Ran A; Gur E; Van de Kar LD
    Eur J Pharmacol; 2004 Feb; 486(1):25-30. PubMed ID: 14751404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional effects of chronic electroconvulsive shock on serotonergic 5-HT(1A) and 5-HT(1B) receptor activity in rat hippocampus and hypothalamus.
    Gur E; Dremencov E; Garcia F; Van de Kar LD; Lerer B; Newman ME
    Brain Res; 2002 Oct; 952(1):52-60. PubMed ID: 12363404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reconsideration of 5-hydroxytryptamine (5-HT)(7) receptor distribution using [(3)H]5-carboxamidotryptamine and [(3)H]8-hydroxy-2-(di-n-propylamino)tetraline: analysis in brain of 5-HT(1A) knockout and 5-HT(1A/1B) double-knockout mice.
    Bonaventure P; Nepomuceno D; Kwok A; Chai W; Langlois X; Hen R; Stark K; Carruthers N; Lovenberg TW
    J Pharmacol Exp Ther; 2002 Jul; 302(1):240-8. PubMed ID: 12065723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-hydroxytryptamine (5-HT)1A autoreceptor adaptive changes in substance P (neurokinin 1) receptor knock-out mice mimic antidepressant-induced desensitization.
    Froger N; Gardier AM; Moratalla R; Alberti I; Lena I; Boni C; De Felipe C; Rupniak NM; Hunt SP; Jacquot C; Hamon M; Lanfumey L
    J Neurosci; 2001 Oct; 21(20):8188-97. PubMed ID: 11588191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased G-protein coupling of serotonin 5-HT(1A) receptors in the brain of 5-HT(1B) knockout mouse.
    Ase AR; Sénécal J; Reader TA; Hen R; Descarries L
    Neuropharmacology; 2002 Jun; 42(7):941-9. PubMed ID: 12069904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of 5-HT(1A) autoreceptors enhances the inhibitory effect of galanin on hippocampal 5-HT release in vivo.
    Yoshitake T; Yoshitake S; Yamaguchi M; Ogren SO; Kehr J
    Neuropharmacology; 2003 Feb; 44(2):206-13. PubMed ID: 12623219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of 5-HT(1A) and 5-HT(1B/1D) receptors on the modulation of acute fluoxetine-induced changes in extracellular 5-HT: the mechanism of action of (+/-)pindolol.
    Dawson LA; Nguyen HQ
    Neuropharmacology; 2000 Apr; 39(6):1044-52. PubMed ID: 10727715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonergic modulation of retinal input to the mouse suprachiasmatic nucleus mediated by 5-HT1B and 5-HT7 receptors.
    Smith BN; Sollars PJ; Dudek FE; Pickard GE
    J Biol Rhythms; 2001 Feb; 16(1):25-38. PubMed ID: 11220775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of chronic paroxetine treatment on dialysate serotonin in 5-HT1B receptor knockout mice.
    Gardier AM; David DJ; Jego G; Przybylski C; Jacquot C; Durier S; Gruwez B; Douvier E; Beauverie P; Poisson N; Hen R; Bourin M
    J Neurochem; 2003 Jul; 86(1):13-24. PubMed ID: 12807420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-Hydroxytryptamine(1A) receptor-stimulated [(35)S]GTPgammaS binding in rat brain: absence of regional differences in coupling efficiency.
    Meller E; Li H; Carr KD; Hiller JM
    J Pharmacol Exp Ther; 2000 Feb; 292(2):684-91. PubMed ID: 10640306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of chronic fluoxetine and WAY-100635 treatment on serotonergic neurotransmission in the frontal cortex.
    Dawson LA; Nguyen HQ; Smith DL; Schechter LE
    J Psychopharmacol; 2002 Jun; 16(2):145-52. PubMed ID: 12095073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.